Barclays’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Barclays's ALAB Position: Q2 2026 in Review
Barclays reduced its Astera Labs (ALAB) stake by 27% in Q2 2026, selling an estimated $112M and leaving 1,130,944 shares worth $546M. The position accounts for 0.1% of the portfolio, ranked #125.
Barclays first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Barclays held 1,130,944 shares of Astera Labs worth $546M as of Q2 2026.
- Barclays sold 423,236 Astera Labs shares in Q2 2026, an estimated $112M.
- Astera Labs made up 0.1% of Barclays's portfolio in Q2 2026, its #125 holding.
- Barclays first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.